SEC Form 4 · accession 0001140361-17-020870
SANGAMO THERAPEUTICS, INC · SGMO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Curt A. Herberts III
Officer — Senior VP & CBO
Period of report
May 11, 2017
Accepted (ET)
May 15, 2017 · 7:42 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001001233
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2,F3 | May 11, 2017 | S | 639 | $6.50 | D | 39,345 | D | |
| Common StockF2,F3 | May 12, 2017 | S | 2,000 | $8.50 | D | 37,345 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1All sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 22, 2017.
- F2Includes 2,000 shares acquired by the Reporting Person on April, 30, 2017 under the Issuer's Employee Stock Purchase Plan.
- F3Includes 3,333 and 12,500 shares subject to restricted stock units (RSUs) granted on December 11, 2014 and December 8, 2015, respectively, that will be issued as such units vest in accordance with their terms.